Home › Interstitial Lung Diseases › NCT05392881

Interstitial Lung Disease Research Unit Biobank

University of Kansas Medical Center Interstitial Lung Disease Research Unit (ILDRU) Biobank

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

1. The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP)
2. The participant is being followed for the presence of autoimmune disease, ILD or other rare lung diseases at TUKHS.
3. The participant is ≥ 18 years of age.
4. The participant has signed an approved consent for this study (living patients only)

About the study

Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.

Sponsor: University of Kansas Medical Center · Participants: 1,000 · Started: Aug 9, 2021

Contact the study team

• Kimberly Donnelly, Ph.D. · Phone: 913-588-6067

Official record on ClinicalTrials.gov — NCT05392881

Locations in the U.S.

Conditions

• Interstitial Lung Diseases
• Sarcoidosis
• Idiopathic Pulmonary Fibrosis
• Pulmonary Fibrosis

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.